Denali Therapeutics Inc. (DNLI)

Healthcare · Biotechnology · NASDAQ

Denali Therapeutics Inc. (DNLI) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $3.45B and a free-cash-flow yield of -11.3%.

Market cap	$3.45B
Trailing P/E	—
FCF yield	-11.3%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live DNLI data on Nama Insights →